- Home
- CEPU vs SUPN Comparison
CEPU vs SUPN Comparison
Compare CEPU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- SUPN
- Stock Information
- Founded
- CEPU 1989
- SUPN 2005
- Country
- CEPU Argentina
- SUPN United States
- Employees
- CEPU N/A
- SUPN N/A
- Industry
- CEPU Electric Utilities: Central
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- SUPN Health Care
- Exchange
- CEPU Nasdaq
- SUPN Nasdaq
- Market Cap
- CEPU 1.6B
- SUPN 1.7B
- IPO Year
- CEPU 2018
- SUPN 2012
- Fundamental
- Price
- CEPU $11.92
- SUPN $31.70
- Analyst Decision
- CEPU Hold
- SUPN Hold
- Analyst Count
- CEPU 1
- SUPN 2
- Target Price
- CEPU $12.00
- SUPN $36.00
- AVG Volume (30 Days)
- CEPU 249.8K
- SUPN 420.5K
- Earning Date
- CEPU 05-12-2025
- SUPN 05-06-2025
- Dividend Yield
- CEPU 2.62%
- SUPN N/A
- EPS Growth
- CEPU N/A
- SUPN N/A
- EPS
- CEPU 0.03
- SUPN 1.11
- Revenue
- CEPU $715,974,448.00
- SUPN $667,997,000.00
- Revenue This Year
- CEPU $26.57
- SUPN N/A
- Revenue Next Year
- CEPU N/A
- SUPN $9.14
- P/E Ratio
- CEPU $35.08
- SUPN $28.49
- Revenue Growth
- CEPU 8.10
- SUPN 11.82
- 52 Week Low
- CEPU $7.07
- SUPN $25.53
- 52 Week High
- CEPU $16.60
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- CEPU 61.06
- SUPN 47.88
- Support Level
- CEPU $10.28
- SUPN $29.16
- Resistance Level
- CEPU $10.75
- SUPN $33.28
- Average True Range (ATR)
- CEPU 0.52
- SUPN 1.19
- MACD
- CEPU 0.12
- SUPN 0.02
- Stochastic Oscillator
- CEPU 97.10
- SUPN 61.65
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.